Browse the evidence

Back squat training elicits greater improvements in lower limb dynamic strength on a nonspecific strength test (45° leg press) compared to front squat training in recreationally trained females, while both variations produce similar hypertrophic adaptations in the lateral thigh.

If your goal is maximum strength, prioritize the back squat. It allows you to lift heavier loads, which translates to better strength gains on other exercises like the leg press. If your goal is just muscle growth in the quads, either squat works equally well, so choose the one you can perform with better technique and less joint pain. You do not need to force yourself to do front squats if they cause shoulder discomfort; the back squat will get you the same muscle growth.

Supplementation with 5g/day of 2'-fucosyllactose (2'-FL) for 6 weeks increases Bifidobacterium abundance in older adults, which is associated with elevated HDL cholesterol, fasting insulin, and FGF21 levels.

If you are an older adult, consuming 5 grams of 2'-fucosyllactose daily for 6 weeks may boost beneficial gut bacteria (Bifidobacterium) and improve metabolic markers like HDL cholesterol and insulin levels. This suggests that prebiotics designed for infants might offer health benefits for aging adults by modulating the gut microbiome.

The metabolic benefits of 2'-fucosyllactose (increased HDL, insulin, FGF21) are contingent on the subject being a 'responder' who experiences a bloom in Bifidobacterium abundance.

Not everyone will benefit from 2'-fucosyllactose. If you don't have Bifidobacterium in your gut, you might not see the metabolic improvements (like better HDL or insulin sensitivity) that others do. Testing your microbiome might help predict if this supplement is right for you.

Adapting bariatric surgery nutritional monitoring protocols (baseline screening, supplementation, periodic testing) to GLP-1RA therapy is recommended to mitigate long-term complications.

Ask your doctor for baseline blood tests for Vitamin D, B12, Iron, Calcium, and Magnesium before or shortly after starting GLP-1 therapy. Repeat these tests annually. Based on results, take a high-quality multivitamin and specific supplements as recommended. This is a proactive step to protect your long-term health.

Short-term intensive insulin therapy (IIT) can improve beta-cell function and induce remission in newly diagnosed Type 2 Diabetes patients.

If you are newly diagnosed, a short course of intensive insulin (2-4 weeks) can 'rest' your pancreas, potentially leading to remission. This is a strategic use of insulin to restore function, not a permanent commitment.

Tirzepatide should be used in combination with CPAP for patients with severe OSA, as the drug takes 6-12 months to significantly reduce AHI, leaving patients at risk during the interim.

If you have severe OSA, do not stop CPAP when starting tirzepatide. The drug takes 6-12 months to significantly reduce your apnea. Use CPAP nightly during this period to protect your heart and safety. After a year, if your AHI has dropped significantly, you and your doctor can discuss tapering off CPAP.

Sarcopenic obesity is a distinct clinical phenotype characterized by high fat mass and low skeletal muscle mass/function, associated with increased risks of frailty, mortality, and metabolic complications, requiring specific diagnostic algorithms (e.g., ESPEN-EASO) for identification.

If you have obesity and are experiencing weakness, fatigue, or functional decline, especially as you age, ask your doctor about sarcopenic obesity. It is not just 'being overweight'; it involves muscle loss which increases health risks. Diagnosis requires specific tests for muscle mass and strength, not just BMI.

The same 25g whey + 5g collagen blend increases myofibrillar protein synthesis during exercise recovery, but does NOT significantly increase muscle connective protein synthesis in the exercised leg compared to placebo.

If you are doing resistance training, your body already significantly boosts connective tissue synthesis. Adding a whey-collagen blend won't necessarily boost connective tissue synthesis further in the working muscles compared to just placebo, though it does help muscle protein synthesis. Focus on the blend for muscle growth, but don't expect it to be a magic bullet for tendon repair in exercised muscles.

Time since Type 2 Diabetes diagnosis is a significant moderator of absolute peak oxygen uptake, with longer duration associated with greater reductions in fitness.

The longer you have Type 2 Diabetes, the more your maximum oxygen uptake tends to drop. However, this decline is gradual. Prioritize exercise early in your diagnosis to preserve fitness, as the most significant drops may occur within the first 5 years.

A low-glycemic index (GI) diet is non-inferior to a whole-grain wheat-fiber diet in preventing arterial wall damage (measured by carotid vessel wall volume) over 3 years in patients with type 2 diabetes.

For people with type 2 diabetes, choosing a low-GI diet (emphasizing lentils, beans, and specific whole grains) is just as effective as a high-wheat-fiber diet for protecting arterial walls over the long term. While the wheat-fiber diet showed a significant increase in arterial wall volume in this study, the low-GI diet did not, suggesting it is a viable and effective strategy for cardiovascular risk reduction.

A low-GI diet preserves renal function (eGFR) better than a whole-grain wheat-fiber diet in patients with type 2 diabetes over 3 years.

If you have type 2 diabetes, a low-GI diet may offer better protection for your kidneys than a standard high-wheat-fiber diet. While both diets are healthy, the low-GI approach helped maintain kidney function (eGFR) better than the wheat-fiber diet, which showed a slight decline in kidney function over 3 years.

Metabolic surgery can reverse or significantly improve existing diabetic microvascular complications, including nephropathy, neuropathy, and retinopathy, independent of the degree of weight loss or glycemic control.

If you have Type 2 Diabetes and are developing kidney or nerve damage, metabolic surgery may offer benefits that standard blood sugar management cannot, potentially reversing or halting this organ damage.

Metabolic surgery is an effective treatment for Non-Alcoholic Steatohepatitis (NASH), significantly reducing liver steatosis, inflammation, and fibrosis, and reducing progression to hepatocellular carcinoma (HCC).

If you have NASH, metabolic surgery is currently the most effective treatment to reverse liver damage and reduce the risk of liver cancer, as current medications and lifestyle changes are largely ineffective.

Metabolic surgery reduces overall and cardiovascular mortality in patients with Type 2 Diabetes and obesity, independent of preoperative BMI.

Metabolic surgery significantly lowers the risk of death from heart disease and other causes in people with Type 2 Diabetes and obesity, offering a survival benefit that intensive medical management does not provide.

Alternative forms of creatine (e.g., creatine HCl, creatine ethyl ester, creatine malate) are not superior to creatine monohydrate (CM) in increasing muscle creatine content or improving exercise performance, despite marketing claims suggesting otherwise.

If you are buying creatine, stick to creatine monohydrate (CM). Alternative forms like creatine HCl, ethyl ester, or malate are marketed as superior, but scientific evidence shows they are not better at increasing muscle creatine or improving performance than standard CM. You are likely paying significantly more (up to 116% higher per gram) for no additional benefit.

GLP-1 receptor agonist-mediated weight loss causes facial volume loss and skin laxity that mimics advanced aging, a phenomenon termed 'Ozempic face,' which is managed through volume restoration (fillers/fat grafting) or skin tightening procedures.

If you are using GLP-1 medications like Ozempic or Wegovy, be aware that rapid weight loss can lead to facial volume loss and skin laxity, making you look older. This is a known side effect of the weight loss itself, not necessarily a unique drug effect on facial fat. You can manage this with fillers, fat grafting, or skin tightening procedures. Discuss these risks with your provider before starting treatment.

Discontinuation of GLP-1 receptor agonists leads to significant weight regain (up to two-thirds of lost weight) and reversal of cardiometabolic improvements.

If you stop taking GLP-1 medications, you are likely to regain a significant portion of the weight you lost. Long-term use is often necessary to maintain weight loss and metabolic benefits. Discuss a long-term plan with your provider before stopping.

In patients with type 2 diabetes, higher diabetes severity (measured by the Individualized Metabolic Surgery score) is associated with significantly lower total body weight loss from semaglutide treatment.

If you have type 2 diabetes, your expected weight loss from semaglutide depends on how severe your diabetes is. Those with milder diabetes (better blood sugar control, no insulin) tend to lose more weight (around 8%) than those with severe diabetes (often on insulin, higher HbA1c), who lose less (around 5.5%). However, the medication still offers important health benefits for blood sugar and heart health regardless of the amount of weight lost, so it remains a recommended treatment for severe cases.

Continuing tirzepatide treatment beyond 12 weeks allows the vast majority (90%) of 'late responders' (those with <5% weight loss at Week 12) to achieve clinically meaningful weight reduction (≥5%) by Week 72.

If you are taking tirzepatide and haven't lost significant weight in the first 3 months, do not stop. Your dose is likely still being increased. Most people who seem like 'non-responders' early on will achieve meaningful weight loss if they stay on the medication until they reach their maximum dose (around 20-25 weeks).

GLP-1 receptor agonists (GLP-1RAs) improve hepatic steatosis and reduce liver fat content in patients with Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD), with some agents also demonstrating the ability to resolve NASH histology.

If you have Type 2 Diabetes and fatty liver, GLP-1 medications (like liraglutide or semaglutide) are strongly supported by evidence to reduce liver fat and improve liver inflammation. They are not yet a standalone 'liver drug' but are recommended for your diabetes, which concurrently helps your liver. Discuss these options with your doctor, especially if you have biopsy-proven NASH, as they can resolve the condition in a majority of patients treated with semaglutide.

Obesity and weight gain drive regional sympathetic nervous system activation, which initiates and worsens cardiometabolic risk factors including hypertension, insulin resistance, and dyslipidemia.

If you are overweight, your body's stress response (sympathetic nervous system) is likely overactive, contributing to high blood pressure and insulin resistance. This is a biological response to excess fat, not just a lack of willpower. Addressing the underlying metabolic drivers (like insulin resistance) is key to reducing this sympathetic overdrive.

GLP-1 receptor agonists reduce cardiovascular risk and promote weight loss, but they cause a transient increase in heart rate that is independent of sympathetic nervous system activation.

GLP-1 medications like Ozempic or Wegovy help with weight loss and heart health. They might slightly increase your resting heart rate, but this is a direct effect on the heart's electrical system, not stress, and does not negate the heart benefits.

Co-ingesting a mixture of three microbial proteases (OPTIZIOME P3) with 25g of pea protein isolate significantly increases early postprandial plasma amino acid availability (0-2h) compared to pea protein alone in healthy adults.

If you are using pea protein, adding a specific microbial protease supplement (like OPTIZIOME P3) with your shake will help your body absorb amino acids faster in the first two hours after drinking it. This is particularly useful around workouts when you want a quick nutrient spike. The study used one capsule (31,875 HUT units) mixed with 25g of pea protein and 300ml of water. It was safe and did not cause stomach issues.

Replacing refined carbohydrates and total calories with healthy fats (specifically MUFA/PUFA from sources like EVOO or nuts) improves cardiometabolic health and lipid profiles more effectively than restricting saturated fats alone.

Stop counting calories and obsessing over fat grams. Instead, replace refined carbohydrates (sugar, white bread, processed grains) with healthy fats like extra-virgin olive oil, nuts, and seeds. Aim for a diet rich in vegetables, whole grains, and moderate amounts of healthy fats (20-50g visible fat daily). This approach improves satiety, stabilizes blood sugar, and reduces cardiovascular risk more effectively than low-fat diets.